From the Los Angeles Medical Center (A.M.L.-G.); Department of Neurology (A.M.L.-G.), and Department of Research & Evaluation (E.G.G., J.B.S., B.H.L.), Southern California Permanente Medical Group, Pasadena; and Department of Epidemiology and Population Health (L.M.N.), Stanford University School of Medicine, CA.
Neurology. 2022 May 3;98(18):e1818-e1827. doi: 10.1212/WNL.0000000000200151.
The goal of this work was to determine whether the prevalence of multiple sclerosis (MS) varies by race and ethnicity.
We conducted a retrospective cohort study of >2.6 million adults from the multiethnic, community-dwelling members of Kaiser Permanente Southern California. The complete electronic health records of individuals with at least 1 code for MS between January 1, 2008 and December 31, 2010 were reviewed. MS prevalence and 95% CIs stratified by age, sex, and race and ethnicity among 2010 members were estimated with binomial regression. Age- and sex-standardized prevalence was estimated according to the 2010 US Census population.
We identified 3,863 patients with MS. The average age of patients with prevalent MS was 51.7 years (SD 13.1 years), and 76.8% were women. The female preponderance was more pronounced among Black (81.2%) and Asian (83.6%) than White (76.3%) or Hispanic (74.5%) individuals with MS. Age- and sex-standardized MS prevalence per 100,000 was similarly high among Black (225.8, 95% CI 207.1-244.5) and White (237.7, 95% CI 228.2-247.2) and significantly lower among Hispanic (69.9, 95% CI 64.4-75.5) and Asian (22.6, 95% CI 17.1-28.1) persons. MS prevalence was highest between the ages of 35 and 64 years and declined after 65 years of age across all racial and ethnic groups. Among adults 18 to 24 years of age, the crude MS prevalence was low but was highest among Black and Hispanic young adults, lower in White people, and lowest in Asian/Pacific Islander individuals (48.5, 25.0, 18.0, and 7.1 per 100,000, respectively).
MS prevalence varies by race and ethnicity, being similarly high in White and Black and significantly lower in Hispanic and Asian persons in Southern California. Taken together with previous studies, these findings indicate that the burden of MS in the US Black community has long been underrecognized. More studies are needed to determine whether MS is an emerging disease among US Hispanic adults and whether MS susceptibility and prevalence vary among Hispanic or Asian individuals from different cultures or ancestral backgrounds.
本研究旨在确定多发性硬化症(MS)的发病是否存在种族差异。
我们对来自凯撒永久南加州多族裔社区成员的 260 多万名成年人进行了回顾性队列研究。对 2008 年 1 月 1 日至 2010 年 12 月 31 日期间至少有 1 例 MS 编码的患者进行了完整的电子健康记录审查。采用二项式回归对 2010 年成员中按年龄、性别和种族及民族分层的 MS 发病率及 95%可信区间进行了估计。根据 2010 年美国人口普查数据,估计了年龄和性别标准化的发病率。
我们共发现 3863 例 MS 患者。发病 MS 患者的平均年龄为 51.7 岁(标准差 13.1 岁),76.8%为女性。在 MS 黑人(81.2%)和亚裔(83.6%)患者中,女性发病率高于白人(76.3%)和西班牙裔(74.5%)患者。在黑人(225.8,95%CI 207.1-244.5)和白人(237.7,95%CI 228.2-247.2)中,年龄和性别标准化 MS 发病率与白人(69.9,95%CI 64.4-75.5)和亚裔(22.6,95%CI 17.1-28.1)患者相似,显著高于西班牙裔(69.9,95%CI 64.4-75.5)和亚裔(22.6,95%CI 17.1-28.1)患者。所有种族和民族的 MS 发病率均在 35 至 64 岁之间最高,65 岁后则逐渐下降。在 18 至 24 岁的成年人中,MS 的发病率虽然较低,但在黑人和西班牙裔年轻人中发病率最高,在白人中发病率较低,在亚裔/太平洋岛民中发病率最低(分别为 48.5、25.0、18.0 和 7.1/100,000)。
MS 的发病率因种族和民族而异,在南加州,白人和黑人的发病率相似,而西班牙裔和亚裔的发病率则显著较低。结合既往研究结果,这些发现表明,长期以来,美国黑人社区的 MS 负担一直被低估。需要进一步研究来确定 MS 是否是美国西班牙裔成年人中的一种新兴疾病,以及不同文化或祖源背景的西班牙裔或亚裔人群的 MS 易感性和发病率是否存在差异。